Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2015 ∙ NACI

Re-Immunization with Polysaccharide 23-Valent Pneumococcal Vaccine (Pneu-P-23)

  • Recommendation
  • Americas
  • Canada
  • Pneumococcal disease
Download:
2015 ∙ Conseil Supérieur des Maladies Infectieuses

Immunization against pneumococcal disease in high risk populations or people aged 65 years of age and older

  • Recommendation
  • Europe
  • Luxembourg
  • Pneumococcal disease
Download:
2015 ∙ JCVI

JCVI interim statement on adult pneumococcal vaccination

  • Recommendation
  • Europe
  • United Kingdom
  • Pneumococcal disease
Download:
2015 ∙ NTAGI

Minutes of the meeting of NTAGI held in 2015

  • Recommendation
  • South-East Asia
  • India
  • Pneumococcal disease
Download:
2015 ∙ Conseil Supérieur de la Santé (CSS)

Recommendations on Vaccination against Pneumococcus for Children and teenagers

  • Recommendation
  • Europe
  • Belgium
  • Pneumococcal disease
Download:
2014 ∙ Van De Vooren, K. Duranti, S. Curto, A. Garattini, L.

Cost effectiveness of the new pneumococcal vaccines: A systematic review of European studies

  • All age groups
  • Pneumococcal disease
  • Economic aspects
  • Coverage
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2014 ∙ Jaiswal, N. Singh, M. Das, R. R. Jindal, I. Agarwal, A. Thumburu, K. K. Kumar, A. Chauhan, A.

Distribution of serotypes, vaccine coverage, and antimicrobial susceptibility pattern of Streptococcus pneumoniae in children living in SAARC countries: a systematic review

  • Newborn
  • Children
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2014 ∙ Hua, C. Barnetche, T. Combe, B. Morel, J.

Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: A systematic review and meta-analysis

  • Adults
  • Influenza
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Loo, J. D. Conklin, L. Deloria Knoll, M. Fleming-Dutra, K. E. Park, D. E. Kirk, J. Johnson, T. S. Goldblatt, D. O'Brien, K. L. Whitney, C. G.

Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules

  • All age groups
  • Pneumococcal disease
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2014 ∙ Usuf, E. Bottomley, C. Adegbola, R. A. Hall, A.

Pneumococcal carriage in sub-Saharan Africa - A systematic review

  • Africa
  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...